Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34421850)
Watch
English
Clinical use of dendritic cells for cancer therapy.
scientific article
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
title
Clinical use of dendritic cells for cancer therapy
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
main subject
dendritic cell
1 reference
based on heuristic
inferred from title
author
Evelien Smits
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
Eva Lion
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
Zwi N Berneman
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
author name string
Sébastien Anguille
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
Viggo F van Tendeloo
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
publication date
1 June 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
volume
15
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
issue
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
page(s)
e257-67
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
cites work
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer immunotherapy via dendritic cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy of cancer in 2012.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autoimmunity associated with immunotherapy of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NK cells: key to success of DC-based cancer vaccines?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer immunotherapy: moving beyond current vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overall survival: patient outcome, therapeutic objective, clinical trial end point, or public health measure?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination of Japanese patients with advanced melanoma with peptide, tumor lysate or both peptide and tumor lysate-pulsed mature, monocyte-derived dendritic cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of survival in Japanese stage IV melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells--a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic cell vaccination in glioblastoma after fluorescence-guided resection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
End points and United States Food and Drug Administration approval of oncology drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib in advanced clear-cell renal-cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evolution of end points for cancer immunotherapy trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy for the treatment of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Harnessing human dendritic cell subsets for medicine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nivolumab plus ipilimumab in advanced melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The anticancer immune response: indispensable for therapeutic success?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemoimmunotherapy: reengineering tumor immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic cancer vaccines: current status and moving forward
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential effects of denileukin diftitox IL-2 immunotoxin on NK and regulatory T cells in nonhuman primates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunomodulatory effects of anti-angiogenic drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of tumour volume on the potential efficacy of therapeutic vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dendritic cell vaccination in acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiation and immunotherapy: a synergistic combination.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970585-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy for advanced renal cell cancer
1 reference
stated in
COCI
retrieved
30 December 2023
reference URL
https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001425.PUB2
Identifiers
DOI
10.1016/S1470-2045(13)70585-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
PubMed publication ID
24872109
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24872109
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872109%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit